Where, when, and how many tuberculosis patients are lost from presumption until treatment initiation? A step by step assessment in a rural district in Zimbabwe.

Diagnosis and treatment cascade Early diagnosis Operational research Pre-diagnosis loss to follow-up Pre-treatment loss to follow-up SORT IT Tuberculosis/diagnosis Tuberculosis/treatment

Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 06 08 2018
revised: 14 10 2018
accepted: 19 10 2018
pubmed: 28 10 2018
medline: 6 2 2019
entrez: 28 10 2018
Statut: ppublish

Résumé

To describe the pre-diagnosis and pre-treatment loss to follow-up (LTFU) in the tuberculosis (TB) care cascade in Guruve (2015-16), a rural district in Zimbabwe. Guruve has 19 rural health centres (RHCs) and one district hospital. In this cohort study, persons ≥15 years of age with presumptive pulmonary TB were tracked from the facility presumptive TB registers to the laboratory registers; if laboratory diagnosed, they were tracked to the district TB register (contains details of all TB patients registered for treatment). Each patient was tracked for 90days after registration as presumptive TB and for 90days after laboratory diagnosis. Environmental health technicians transported sputum specimens from the health facilities to the laboratories (n=3). Of 2974 persons with presumptive TB, pre-diagnosis LTFU occurred in 575 (19%, 95% confidence interval 18-21%). Associated factors included registration at a RHC, at a facility more than 2km from the laboratory, and absence of an environmental health technician. Of 162 laboratory diagnosed pulmonary TB patients, pre-treatment LTFU occurred in 19 (12%, 95% confidence interval 8-18%). The presumptive TB register was helpful to assess the pre-diagnosis gaps beginning from presumption. Pre-diagnosis LTFU can be reduced by placement of an environmental health technician at all facilities.

Identifiants

pubmed: 30368019
pii: S1201-9712(18)34559-4
doi: 10.1016/j.ijid.2018.10.013
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113-120

Informations de copyright

Copyright © 2018 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Admire S Murongazvombo (AS)

Ministry of Health and Child Care, Mashonaland Central Province, Zimbabwe. Electronic address: asmronger@gmail.com.

Riitta A Dlodlo (RA)

International Union Against Tuberculosis and Lung Disease, Bulawayo, Zimbabwe. Electronic address: rdlodlo@theunion.org.

Hemant Deepak Shewade (HD)

International Union Against Tuberculosis and Lung Disease (The Union), South East Asia Office, New Delhi, India; International Union Against Tuberculosis and Lung Disease (The Union), Paris, France. Electronic address: hemantjipmer@gmail.com.

Valerie Robertson (V)

College of Health Sciences, Department of Medical Microbiology, University of Zimbabwe, Harare, Zimbabwe; Biomedical Research and Training Institute, Harare, Zimbabwe. Electronic address: vrobertsonzim@yahoo.co.uk.

Susumu Hirao (S)

Research Institute of Tuberculosis - Japan Anti-Tuberculosis Association, Tokyo, Japan. Electronic address: hirao@jata.or.jp.

Elijah Pikira (E)

Ministry of Health and Child Care, Mashonaland Central Province, Zimbabwe. Electronic address: elijahpikira@gmail.com.

Cedric Zhanero (C)

Ministry of Health and Child Care, Mashonaland Central Province, Zimbabwe. Electronic address: cedriczhanero@gmail.com.

Rachael K Taruvinga (RK)

Ministry of Health and Child Care, Mashonaland Central Province, Zimbabwe. Electronic address: rktaruvinga@gmail.com.

Precious Andifasi (P)

Ministry of Health and Child Care, Mashonaland Central Province, Zimbabwe. Electronic address: pandifasi@gmail.com.

Cremence Tshuma (C)

Ministry of Health and Child Care, Mashonaland Central Province, Zimbabwe. Electronic address: tshuma.cremance@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH